The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The retrospective analysis of nephrotoxicity for cisplatin dose of CRT compared 100mg/m2 to 80mg/m2 for head and neck cancer (HNC) patients.
 
Tomoyo Oguri
No Relationships to Disclose
 
Kenji Nakano
No Relationships to Disclose
 
Naoki Fukuda
No Relationships to Disclose
 
Kuniki Kawaguchi
No Relationships to Disclose
 
Tetsuya Urasaki
No Relationships to Disclose
 
Masatoshi Nishizawa
No Relationships to Disclose
 
Mayu Yunokawa
Consulting or Advisory Role - AstraZeneca
 
Makiko Ono
No Relationships to Disclose
 
Shinichiro Taira
No Relationships to Disclose
 
Junichi Tomomatsu
No Relationships to Disclose
 
Takashi Toshiyasu
No Relationships to Disclose
 
Hiroki Mitani
No Relationships to Disclose
 
Shunji Takahashi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Eisai; MSD; Novartis; Sanofi; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Novartis